drugset / Trial / NCT03451890
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will be conducted to evaluate the safety, tolerability, and pharmacokinetics of single ascending oral doses of E2730 in healthy adult participants.
Timeline
- Start
- 2018-02-09
- Primary completion
- 2018-09-26
- Completion
- 2018-09-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | E2730 | Unknown | 40 mg | Oral |
| Subject | E2730 | Unknown | 80 mg | Oral |
| Subject | E2730 | Unknown | 120 mg | Oral |
| Subject | E2730 | Unknown | 160 mg | Oral |
Indications
No indication recorded.